Testosterone Cypionate Injection: What It Is and How It Works

This guide explains what testosterone cypionate is, how it behaves in the body, and what published sources document about its use, side effects, and administration. It is written for readers already familiar with anabolic steroids and hormone therapy who want a factual account of this esterified form of testosterone.

What Is Testosterone Cypionate Used For

Testosterone cypionate is a synthetic ester of testosterone used to treat male hypogonadism, a condition marked by low serum testosterone and symptoms such as decreased energy and libido. According to the FDA label, endogenous androgens are responsible for normal growth and development of the male sex organs and maintenance of secondary sex characteristics, including body musculature, male pattern hair distribution, and vocal cord thickening. The label notes that drugs in this class cause retention of nitrogen, sodium, potassium, and phosphorus, and that androgens increase protein anabolism and decrease protein catabolism when caloric and protein intake is sufficient.

A 2005 review in Treatments in Endocrinology states that androgen replacement therapy in hypogonadal men has potential benefits including improved sexual function, enhanced sense of well-being, increased lean body mass, decreased body fat, and increased bone density. The same review describes weekly-to-biweekly injections of testosterone cypionate or testosterone enanthate as widely used because they are economical and generally well tolerated.

How Is Testosterone Cypionate Made

Testosterone cypionate is manufactured by esterifying testosterone at the 17-beta hydroxyl group with cyclopentylpropionic acid, creating a less polar compound than free testosterone. This esterification allows the compound to be dissolved in oil for intramuscular injection. The FDA label explains that testosterone esters in oil injected intramuscularly are absorbed slowly from the lipid phase, which permits dosing intervals of two to four weeks. Once in circulation, testosterone is metabolized primarily in the liver to various 17-keto steroids through two pathways, and about 90 percent of a dose is excreted in the urine as glucuronic and sulfuric acid conjugates.

Testosterone Cypionate Benefits

The benefits attributed to testosterone cypionate stem from its role in restoring physiological testosterone levels in hypogonadal men. The 2005 review notes that androgen therapy carries potential benefits such as improved sexual function, increased lean body mass, decreased body fat, and increased bone density. The FDA label states that androgens have been reported to stimulate red blood cell production by enhancing erythropoietic stimulation factor, and that they promote nitrogen retention and protein anabolism when adequate calories and protein are consumed. In tissue, the activity of testosterone depends on its reduction to dihydrotestosterone, which binds to cytosol receptor proteins and initiates transcription events related to androgen action.

Cypionate Testosterone and Other Esters Compared

Testosterone cypionate has a half-life of approximately eight days when injected intramuscularly, according to the FDA label. This is comparable to testosterone enanthate, which the 2005 review describes as another widely used long-acting ester with similar dosing intervals. A 2023 review in Drug, Healthcare and Patient Safety notes that multiple formulations of injectable testosterone exist, including cypionate, enanthate, and undecanoate, and that injectable therapy remains the most cost-effective option appropriate for most patients as initial therapy. Testosterone undecanoate is a longer-acting ester that can be administered quarterly, while short-acting esters such as propionate require more frequent injection. The choice among esters depends on desired dosing frequency and individual response.

Testosterone Cypionate Side Effects

The FDA label lists adverse reactions reported with androgens including gynecomastia, excessive frequency and duration of penile erections, oligospermia at high doses, hirsutism, male pattern baldness, seborrhea, acne, myocardial infarction, stroke, retention of sodium and water, nausea, cholestatic jaundice, alterations in liver function tests, suppression of clotting factors, polycythemia, changes in libido, headache, anxiety, depression, hypersensitivity reactions, venous thromboembolism, and inflammation and pain at the injection site. The label also notes that exogenous androgen administration inhibits endogenous testosterone release through feedback inhibition of pituitary luteinizing hormone, and that spermatogenesis may be suppressed at large doses through inhibition of follicle-stimulating hormone.

A 2022 meta-analysis in The Journal of Urology compared hematocrit changes across testosterone formulations and found that intramuscular testosterone cypionate or enanthate resulted in a mean hematocrit increase of 4.0 percent compared to placebo, significantly higher than the increase seen with transdermal patches. A 2022 study in Steroids using animal models reported that supraphysiological doses of testosterone cypionate reduced neuronal density in the locus coeruleus area of rat brains, suggesting neuronal death caused by intracellular calcium imbalance. The 2005 review recommends annual measurement of hematocrit and prostate cancer screening for men over 50 on androgen therapy.

Testosterone Cypionate Injection Instructions

The FDA label states that testosterone cypionate can be given at intervals of two to four weeks due to its slow absorption from the lipid phase after intramuscular injection. The 2005 review describes a typical regimen of 200 mg every two weeks or 300 mg every three weeks administered by intramuscular injection. A 1984 review in Annual Review of Medicine similarly recommends 200 mg every two weeks or 300 mg every three weeks for treatment of adult male hypogonadism. The FDA label notes that in plasma, 98 percent of testosterone is bound to a specific testosterone-estradiol binding globulin, and about 2 percent is free, with the free concentration determining the hormone's half-life.

A 2026 study in the Indian Journal of Endocrinology and Metabolism examined weekly subcutaneous self-administration of 50 mg testosterone cypionate in female-to-male transgender patients and reported that 81 percent achieved target testosterone levels above 300 ng/dL after six months. A 2018 review in the Brazilian Journal of Gynecology and Obstetrics states that plasmatic testosterone levels should be kept within male physiological ranges of 300 to 1,000 ng/dL during hormonal treatment, and that male physical characteristics can be seen in almost all users after six months of therapy, with maximum virilization effects usually achieved after three to five years. These are descriptive findings from published sources; decisions about injection technique, dosing frequency, and target levels are clinical matters that belong with a qualified healthcare provider.

Testosterone Cypionate Products

Testosterone cypionate is sold in multiple concentrations and vial sizes. Common formulations include testosterone cypionate 200mg ml 10ml vial presentations and testosterone cypionate 250 mg/mL solutions. Products are typically labeled by concentration and volume, and selection depends on prescribed dosing regimen and frequency of administration.

This guide is general information compiled from published labels, reviews, and clinical studies. It is not medical advice. Decisions about testosterone therapy, including whether to use it, what formulation to choose, how much to take, and how to administer it, belong with a qualified clinician who can assess individual health status and monitor for adverse effects.